Garcia HH, Nash TE, Del Brutto OH, 2014. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol 13: 1202–1215.
Nash TE, Garcia HH, 2011. Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol 7: 584–594.
Bruno E, Bartoloni A, Zammarchi L, Strohmeyer M, Bartalesi F, Bustos JA, Santivanez S, Garcia HH, Nicoletti A, Group CPS, 2013. Epilepsy and neurocysticercosis in Latin America: a systematic review and meta-analysis. PLoS Negl Trop Dis 7: e2480.
Carabin H, Ndimubanzi PC, Budke CM, Nguyen H, Qian Y, Cowan LD, Stoner JA, Rainwater E, Dickey M, 2011. Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis 5: e1152.
Winkler AS, 2012. Neurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics, diagnosis, and management. Pathog Glob Health 106: 261–274.
Coral-Almeida M, Gabriel S, Abatih EN, Praet N, Benitez W, Dorny P, 2015. Taenia solium human cysticercosis: a systematic review of sero-epidemiological data from endemic zones around the world. PLoS Negl Trop Dis 9: e0003919.
Mwape KE, Phiri IK, Praet N, Speybroeck N, Muma JB, Dorny P, Gabriel S, 2013. The incidence of human cysticercosis in a rural community of eastern Zambia. PLoS Negl Trop Dis 7: e2142.
Braae UC, Saarnak CF, Mukaratirwa S, Devleesschauwer B, Magnussen P, Johansen MV, 2015. Taenia solium taeniosis/cysticercosis and the co-distribution with schistosomiasis in Africa. Parasit Vectors 8: 323.
United States Department of State, 2010. Zambia International Religious Freedom Report 2010. Available at: https://www.state.gov/j/drl/rls/irf/2010/148728.htm. Accessed September 3, 2017.
Carabin H, Millogo A, Praet N, Hounton S, Tarnagda Z, Ganaba R, Dorny P, Nitiema P, Cowan LD; Evaluation du Fardeau Economique de la Cysticercose Au Burkina F, 2009. Seroprevalence to the antigens of Taenia solium cysticercosis among residents of three villages in Burkina Faso: a cross-sectional study. PLoS Negl Trop Dis 3: e555.
Trinies V, Garn JV, Chang HH, Freeman MC, 2016. The impact of a school-based water, sanitation, and hygiene program on absenteeism, diarrhea, and respiratory infection: a matched-control trial in Mali. Am J Trop Med Hyg 94: 1418–1425.
Noh J, Rodriguez S, Lee YM, Handali S, Gonzalez AE, Gilman RH, Tsang VC, Garcia HH, Wilkins PP, 2014. Recombinant protein- and synthetic peptide-based immunoblot test for diagnosis of neurocysticercosis. J Clin Microbiol 52: 1429–1434.
Corstjens PL, de Dood CJ, Priest JW, Tanke HJ, Handali S; Cysticercosis Working Group in Peru, 2014. Feasibility of a lateral flow test for neurocysticercosis using novel up-converting nanomaterials and a lightweight strip analyzer. PLoS Negl Trop Dis 8: e2944.
Handali S et al. 2010. Development and evaluation of a magnetic immunochromatographic test to detect Taenia solium, which causes taeniasis and neurocysticercosis in humans. Clin Vaccine Immunol 17: 631–637.
Handali S et al. 2010. Multiantigen print immunoassay for comparison of diagnostic antigens for Taenia solium cysticercosis and taeniasis. Clin Vaccine Immunol 17: 68–72.
Goodhew EB, Priest JW, Moss DM, Zhong G, Munoz B, Mkocha H, Martin DL, West SK, Gaydos C, Lammie PJ, 2012. CT694 and pgp3 as serological tools for monitoring trachoma programs. PLoS Negl Trop Dis 6: e1873.
Moss DM, Chard AN, Trinies V, Doumbia S, Freeman MC, Lammie PJ, 2017. Serological responses to filarial antigens in Malian children attending elementary schools. Am J Trop Med Hyg 96: 229–232.
Kulldorf M, 1997. A spatial scan statistic. Commun Stat Theory 26: 1481–1496.
Kulldorf MaIMS, Inc., 2015. SaTScanTM v9.4: Software for the Spatial and Space-Time Scan Statistics. Available at: http://www.satscan.org/. Accessed June 12, 2017.
Coulibaly YI et al. 2015. The impact of six annual rounds of mass drug administration on Wuchereria bancrofti infections in humans and in mosquitoes in Mali. Am J Trop Med Hyg 93: 356–360.
Maiga YDM, Bouteille B, Konate A, Diarra M, Maiga M, Marjolet M, 2009. A propos d’un cas autochtone de neurocysticercose au Mali (premier cas de la litterature?). Bull Soc Pathol Exot 102: 211–214.
Bureau of Democracy HR, and Labor, 2010. International Religious Freedom Report, 2010. Available at: https://www.state.gov/j/drl/rls/irf/2010/148665.htm. Accessed October 10, 2017.
(OCHA) UNOftCoHA, 2013. Mali: Complex Emergency, Situation Report No. 39. Available at: https://reliefweb.int/sites/reliefweb.int/files/resources/Sitrep39_EN.pdf. Accessed September 12, 2017.
Kellar KL, Kalwar RR, Dubois KA, Crouse D, Chafin WD, Kane BE, 2001. Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry 45: 27–36.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 739 | 707 | 21 |
Full Text Views | 580 | 17 | 5 |
PDF Downloads | 149 | 19 | 5 |
Blood samples from 805 students attending 42 elementary schools in Mopti, Sikasso, and Koulikoro regions, and Bamako district in Mali participated in a school water, sanitation, and hygiene intervention. Immunoglobulin (Ig) G responses to several antigens/pathogens were assessed by a multiplex bead assay (MBA), and the recombinant Taenia solium T24H antigen was included. Of all students tested, 8.0% were positive to rT24H, but in some schools 25–30%. A cluster of 12 widespread school locations showed not only a relative risk of 3.23 for T. solium exposure and significantly higher IgG responses (P < 0.001) but also significantly lower elevation (P = 0.04) (m, above sea level) compared with schools outside the cluster. All schools at elevations < 425 m showed significantly higher IgG responses (P = 0.017) than schools at elevations ≥ 425 m. The MBA is an excellent serological platform that provides cost-effective opportunities to expand testing in serosurveys.
Financial support: Funding for this study was provided by Dubai Cares Foundation (DCF), and DCF had no involvement in the study design, sample collection, analysis, or interpretation of the data.
Authors’ addresses: Delynn M. Moss, Waterborne Disease Prevention Branch, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, E-mail: dmm3@cdc.gov. Sukwan Handali, Ryan E. Wiegand, and Patrick J. Lammie, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, E-mails: ahi0@cdc.gov, fwk2@cdc.gov, and pjl1@cdc.gov. Anna N. Chard, Victoria Trinies, and Matthew C. Freeman, Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA, E-mails: achard@emory.edu, vtrinies@gmail.com, and mcfreem@emory.edu. Stevan Bullard, Geospatial Research, Analysis and Services Program, Division of Toxicology and Human Health Sciences, Centers for Disease Control and Prevention, Atlanta, GA, E-mail: asz3@cdc.gov. Seydou Doumbia, Faculty of Medicine and Odontostomatology, Malaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, E-mail: sdoumbi@icermali.org.
Garcia HH, Nash TE, Del Brutto OH, 2014. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol 13: 1202–1215.
Nash TE, Garcia HH, 2011. Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol 7: 584–594.
Bruno E, Bartoloni A, Zammarchi L, Strohmeyer M, Bartalesi F, Bustos JA, Santivanez S, Garcia HH, Nicoletti A, Group CPS, 2013. Epilepsy and neurocysticercosis in Latin America: a systematic review and meta-analysis. PLoS Negl Trop Dis 7: e2480.
Carabin H, Ndimubanzi PC, Budke CM, Nguyen H, Qian Y, Cowan LD, Stoner JA, Rainwater E, Dickey M, 2011. Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis 5: e1152.
Winkler AS, 2012. Neurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics, diagnosis, and management. Pathog Glob Health 106: 261–274.
Coral-Almeida M, Gabriel S, Abatih EN, Praet N, Benitez W, Dorny P, 2015. Taenia solium human cysticercosis: a systematic review of sero-epidemiological data from endemic zones around the world. PLoS Negl Trop Dis 9: e0003919.
Mwape KE, Phiri IK, Praet N, Speybroeck N, Muma JB, Dorny P, Gabriel S, 2013. The incidence of human cysticercosis in a rural community of eastern Zambia. PLoS Negl Trop Dis 7: e2142.
Braae UC, Saarnak CF, Mukaratirwa S, Devleesschauwer B, Magnussen P, Johansen MV, 2015. Taenia solium taeniosis/cysticercosis and the co-distribution with schistosomiasis in Africa. Parasit Vectors 8: 323.
United States Department of State, 2010. Zambia International Religious Freedom Report 2010. Available at: https://www.state.gov/j/drl/rls/irf/2010/148728.htm. Accessed September 3, 2017.
Carabin H, Millogo A, Praet N, Hounton S, Tarnagda Z, Ganaba R, Dorny P, Nitiema P, Cowan LD; Evaluation du Fardeau Economique de la Cysticercose Au Burkina F, 2009. Seroprevalence to the antigens of Taenia solium cysticercosis among residents of three villages in Burkina Faso: a cross-sectional study. PLoS Negl Trop Dis 3: e555.
Trinies V, Garn JV, Chang HH, Freeman MC, 2016. The impact of a school-based water, sanitation, and hygiene program on absenteeism, diarrhea, and respiratory infection: a matched-control trial in Mali. Am J Trop Med Hyg 94: 1418–1425.
Noh J, Rodriguez S, Lee YM, Handali S, Gonzalez AE, Gilman RH, Tsang VC, Garcia HH, Wilkins PP, 2014. Recombinant protein- and synthetic peptide-based immunoblot test for diagnosis of neurocysticercosis. J Clin Microbiol 52: 1429–1434.
Corstjens PL, de Dood CJ, Priest JW, Tanke HJ, Handali S; Cysticercosis Working Group in Peru, 2014. Feasibility of a lateral flow test for neurocysticercosis using novel up-converting nanomaterials and a lightweight strip analyzer. PLoS Negl Trop Dis 8: e2944.
Handali S et al. 2010. Development and evaluation of a magnetic immunochromatographic test to detect Taenia solium, which causes taeniasis and neurocysticercosis in humans. Clin Vaccine Immunol 17: 631–637.
Handali S et al. 2010. Multiantigen print immunoassay for comparison of diagnostic antigens for Taenia solium cysticercosis and taeniasis. Clin Vaccine Immunol 17: 68–72.
Goodhew EB, Priest JW, Moss DM, Zhong G, Munoz B, Mkocha H, Martin DL, West SK, Gaydos C, Lammie PJ, 2012. CT694 and pgp3 as serological tools for monitoring trachoma programs. PLoS Negl Trop Dis 6: e1873.
Moss DM, Chard AN, Trinies V, Doumbia S, Freeman MC, Lammie PJ, 2017. Serological responses to filarial antigens in Malian children attending elementary schools. Am J Trop Med Hyg 96: 229–232.
Kulldorf M, 1997. A spatial scan statistic. Commun Stat Theory 26: 1481–1496.
Kulldorf MaIMS, Inc., 2015. SaTScanTM v9.4: Software for the Spatial and Space-Time Scan Statistics. Available at: http://www.satscan.org/. Accessed June 12, 2017.
Coulibaly YI et al. 2015. The impact of six annual rounds of mass drug administration on Wuchereria bancrofti infections in humans and in mosquitoes in Mali. Am J Trop Med Hyg 93: 356–360.
Maiga YDM, Bouteille B, Konate A, Diarra M, Maiga M, Marjolet M, 2009. A propos d’un cas autochtone de neurocysticercose au Mali (premier cas de la litterature?). Bull Soc Pathol Exot 102: 211–214.
Bureau of Democracy HR, and Labor, 2010. International Religious Freedom Report, 2010. Available at: https://www.state.gov/j/drl/rls/irf/2010/148665.htm. Accessed October 10, 2017.
(OCHA) UNOftCoHA, 2013. Mali: Complex Emergency, Situation Report No. 39. Available at: https://reliefweb.int/sites/reliefweb.int/files/resources/Sitrep39_EN.pdf. Accessed September 12, 2017.
Kellar KL, Kalwar RR, Dubois KA, Crouse D, Chafin WD, Kane BE, 2001. Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry 45: 27–36.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 739 | 707 | 21 |
Full Text Views | 580 | 17 | 5 |
PDF Downloads | 149 | 19 | 5 |